TN CM sanctions ₹25 crore for medicines for mucormycosis, essentials

As of Monday, contributions of about ₹280.20 crore have been received by the CM’s Public Relief Fund

June 07, 2021 03:31 pm | Updated 03:37 pm IST - CHENNAI

A patient being screened for Mucormycosis at Rajiv Gandhi Government General Hospital. Photograph used for representational purposes only

A patient being screened for Mucormycosis at Rajiv Gandhi Government General Hospital. Photograph used for representational purposes only

Tamil Nadu Chief Minister M.K. Stalin has ordered the using of ₹25 crore from the Chief Minister’s Public Relief Fund (CMPRF) towards procuring essential medicines, including those used to treat patients with mucormycosis.

As of Monday, contributions of about ₹280.20 crore have been received by the CMPRF, following an appeal issued by Mr. Stalin asking for support for the State to fight COVID-19, an official release said.

The CM has already sanctioned ₹50 crore from the CMPRF for procuring essential drugs and liquid oxygen and had also sanctioned ₹50 crore for procuring over RT-PCR test kits. He had also sanctioned ₹41.40 crore for importing oxygen concentrators and other equipment.

Details on how to contribute to the fund, can be found here .

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.